Pediatric Clinical Trials Market Size to Hit Around USD 27.65 Bn by 2033
The pediatric clinical trials market size was exhibited at USD 16.50 billion in 2023 and is projected to hit around USD 27.65 billion by 2033, growing at a CAGR of 5.3% during the forecast period 2024 to 2033.
Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8918
Pediatric Clinical Trials Market Key Takeaways:
The global market has noticed critical growth on account of the rising R&D investments by pharmaceutical companies owing to the high burden of chronic and infectious diseases among the pediatrics. The COVID-19 pandemic has contributed significantly to the demand for pediatric clinical trials, owing to the growing demand for vaccines to curb the spread of the infection. For instance, In March 2023, the biotechnology company Moderna Inc. reported that it is recruiting patients aged between 6 -12 years for clinical trials of mRNA-1273 COVID-19 vaccines.
Such factors are likely to have a positive impact on the market. Rising awareness among the parents for pediatric clinical trials for treating serious infections and chronic diseases, and a significant number of CROs conducting pediatric trials are also driving the market. Autism is one of the common disorders in children. As per the CDC, 1 in 44 children in the U.S. had autism in 2018. The high burden of autism among kinds is likely to drive the demand for autism clinical trials and thus is anticipated to promote market growth. Public organizations globally are providing funding to develop better treatment for the pediatric population.
For instance, in May 2022, the Australian Government’s Medical Research Future Fund (MRFF) funded USD 1.8 million to the researchers for developing a treatment for juvenile idiopathic arthritis. Such actions are further promoting the pediatric clinical trial market. Recruitment and patient retention are one of the major challenges for pediatric clinical research. However, in recent years there has been a gradual adoption of decentralized trials for easing the pediatric trials. For instance, in June 2023, a global organization, Clinical Oncology Group (COG) conducted clinical research for children and adolescents partnered with Signify Heath, a platform used for conducting decentralized trials.
This partnership was intended to conduct clinical trials for children suffering from leukemia. Such partnerships are likely to increase the adoption of decentralized trials and are expected to pediatric clinical trials faster. During the pandemic, pediatric clinical trials were halted to reduce the spread of the virus. This affected the recruitment of young patients for new trials. Such incidences are expected to have a negative impact on market growth. However, owing to the urgent need for advanced therapeutics many clinical trials were resumed. For instance, in August 2020, a biotech company, Cerecor Inc. resumed the Phase 1b clinical study of CERC-002 for treating severe pediatric-onset Crohn’s disease. Resuming clinical studies owing to the growing demand for innovative treatments has enhanced the market growth.
Pediatric Clinical Trials Market By Phase Insights
On the basis of phase, the global market has been further sub-segmented into phases I, II, III, and IV pediatric clinical trials. The phase II trials segment dominated the market in 2023 and accounted for the maximum share of more than 32.00% of the global revenue. Phase II trials are conducted on children to investigate the safety and efficacy of the intervention. Phase II studies consist of a high number of pediatric subjects; moreover, studies in this phase are more complex than those in other phases. Generally, medicinal product testing in children is deferred until the trials reach phase III, which examines the efficacy, acceptability, and adverse effects.
Pediatric Clinical Trials Market By Study Design Insights
On the basis of study design, the global market has been further categorized into treatment studies and observational studies. Treatment studies have accounted for the maximum revenue share of the global market of more than 65.00% in 2023. According to Clinicaltrials.gov, from 2000 to 2023, a total of 53,060 pediatric trials were registered, with 36,136 (68.1%) including treatment studies. However, the majority of treatment pediatric trials were single site (61.4%), small-scale (58.9%), randomized (66.0%), and had no masking (56.9%), there were fewer drug trials conducted throughout time.
Pediatric Clinical Trials Market By Therapeutic Areas Insights
On the basis of therapeutic areas, the global market has been further segmented into infectious diseases, oncology, autoimmune/inflammation, respiratory disorders, mental health disorders, and others. The oncology therapeutic area segment accounted for the second-largest revenue share of more than 20.0% in the global market in 2023. Cancer is one of the major causes of death worldwide. It is estimated that cancer cases among children below the age of 19 years are likely to reach 291,000 by 2040. The Molecular Characterization Initiative is offered through NCI’s Childhood Cancer Data Initiative, which was launched in 2023 to promote data sharing and collection of new data among researchers who study childhood cancers.
Pediatric Clinical Trials Market By Regional Insights
On the basis of geographies, the market has been further divided into North America, Asia Pacific, Latin America, Europe, Middle East & Africa. North America dominated the global market in 2023 and accounted for the largest share of 44.0% of the global revenue. This is due to the presence of a significant number of pharmaceutical companies and CROs conducting pediatric trials in the region. Apart from this, public organizations are also undertaking active initiatives to support pediatric research. For instance, the current NIH funding for pediatric research accounts for USD 4 billion. Such initiatives are further contributing to the market growth in this region.
Some of the prominent players in the pediatric clinical trials market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2023 to 2033. For this study, Nova one advisor, Inc. has segmented the pediatric clinical trials market
Phase
Study Design
Therapeutic Areas
Regional
Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8918?
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 2nd Floor,Shreeleela Plaza, Baner Road, Pune, Maharashtra - 411045
Call: USA - + 1 804 441 9344| IND - + 91 87933 22019 | Europe: +44 2080772818
领英推荐
Reasons to Purchase this Report
Nova One Advisor Group Offer Other Reports:
Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.
Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.
Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.
Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.
U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.
U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.
T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.
Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.
Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.
Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.
U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.
Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.
Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.
U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.
Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.
U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.
Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.
Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.
Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.
U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.
U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.
Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.
Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.
U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.